Advertisement

Topics

Dignitana’s cooling cap system gets FDA nod to reduce hair loss during chemotherapy

01:49 EDT 4 Jul 2017 | Medical Business Review

Dignitana has secured expanded approval from the US Food and Drug Administration (FDA) for its DigniCap cooling system to reduce hair loss (alopecia) during chemotherapy.

Original Article: Dignitana’s cooling cap system gets FDA nod to reduce hair loss during chemotherapy

NEXT ARTICLE

More From BioPortfolio on "Dignitana’s cooling cap system gets FDA nod to reduce hair loss during chemotherapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...